Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex. (Q51028257)
Jump to navigation
Jump to search
scientific article published in November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex. |
scientific article published in November 2014 |
Statements
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex (English)
Juergen Meixensberger
Ronald Koschny
Christina Boehm
Heidrun Holland
Li-Xin Xu
Wolfgang Krupp
Wolf C Mueller
Manfred Bauer
Marius Keller
Peter Sinn
Henning Walczak
Tom M Ganten
Thomas Koschny
1 November 2014